June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Management of Malignant Eyelid Tumors by Primary Reconstruction: Evaluation of Long-term Outcomes
Author Affiliations & Notes
  • Yinan Han
    Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China
  • Jiang Qian
    Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China
  • Yifei Yuan
    Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China
  • Yingwen Bi
    Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China
  • Yiqun Yao
    Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China
  • Kang Xue
    Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China
  • Chenghua Wei
    Ophthalmology, Yijishan Hospital of Wannan Medical College, Wuhu, China
  • Jie Guo
    Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China
  • Footnotes
    Commercial Relationships Yinan Han, None; Jiang Qian, None; Yifei Yuan, None; Yingwen Bi, None; Yiqun Yao, None; Kang Xue, None; Chenghua Wei, None; Jie Guo, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6371. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yinan Han, Jiang Qian, Yifei Yuan, Yingwen Bi, Yiqun Yao, Kang Xue, Chenghua Wei, Jie Guo, ; Management of Malignant Eyelid Tumors by Primary Reconstruction: Evaluation of Long-term Outcomes. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6371.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To study long-term outcomes of primary reconstruction in surgical excision of malignant tumors.

 
Methods
 

We analyzed the data of 46 eyes with eyelid malignant tumors undertaken surgical excision during 2005 to 2008 in Shanghai Eye and ENT Hospital. The cancer type, location, type of the procedure, local recurrence, lymph node enlargement and survival rate were evaluated.

 
Results
 

Among 46 cases, basal cell carcinoma (21 cases), sebaceous gland carcinoma (19 cases), squamous cell carcinoma(4 cases), lymphoma(1 cases) and Merkel cell carcinoma(1 case) were included. Various techniques were used, such as Hughes procedure, Cutler-Beard procedure, myocutaneous advancement flap, semicircular rotational flap, lateral cantholysis, periosteal strip, free autogenous tarsal graft, full-thickness skin graft and glabella flap, et al. Median follow-up was 59.7±12.9 months (minimum/maximum 15 to 84). According to the Kaplan-Meier survival estimate, the overall 5 year, 7 year survival rate was 93.5%, 91.3% respectively. 5 year tumor- free survival rate was 91.1%. During follow-up period, local recurrence occurred in two cases who refused further treatment and still alive by last follow-up. Cervical lymph node enlargement was detected in two cases, followed by lymph node debridement. Both of them were in good condition till now. Four patients died, two of metastasis, one of old age, and one of primary esophageal carcinoma. Mild entropion and extropion were occurred in two cases. One had trichiasis. Others acquired normal eyelid position. Satisfaction in comfort and appearance was achieved in 87% cases.

 
Conclusions
 

Eyelid reconstruction techniques could effectively repair the defects after resection of eyelid malignant tumors and lead to satisfactory clinical results. Active surveillance is still mandatory.

 
 
8 months after surgery
 
8 months after surgery
 
 
Basal cell carcinoma
 
Basal cell carcinoma
 
Keywords: 526 eyelid • 624 oncology • 650 plasticity  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×